SAN FRANCISCO (GenomeWeb News) – The JP Morgan Healthcare Conference wrapped up today with a handful of life science tools and molecular diagnostics companies presenting to investors.

Affymetrix

Earlier this week Affymetrix announced a restructuring aimed at returning the firm to profitability and revenue growth. That restructuring included an 8 percent workforce reduction, or 100 employees.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Researchers find that a personalized medicine approach could help people who experience pain while taking statins, New Scientist reports.

US National Science Foundation is continuing its responsible research conduct training policy despite its flaws, ScienceInsider reports.

A CRISPR-themed meeting explored how the tool could and should be used, Wired reports.

In Science this week: database of proteins' effects on cancer, targeted error correction sequencing, and more.